Hyperdopaminergia (elevations in D2/D3 receptor availability) was proposed to underline manic episodes, while increased dopamine transporter (DAT), resulting in reduced dopaminergic function, was suggested for depressive episodes. The gene discussed is SLC6A3; the disease is major depressive disorder.